Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending November 07, 2007. The report details a specific corporate action regarding the repurchase of the company's own ordinary shares, executed in accordance with shareholder authority granted at the Annual General Meeting on May 23, 2007.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share repurchase transaction:
- Shares Purchased: 1,940,000 ordinary shares of 25 pence each.
- Purchase Price: 1,208.54 pence per share.
- Treasury Holdings: Following the purchase, GSK holds 480,129,158 shares in Treasury.
- Treasury Percentage: Treasury shares represent 8.66% of total voting rights.
- Shares in Issue: 5,545,093,309 shares (excluding Treasury shares).
Material Changes
The material change reported is the reduction of outstanding shares through the acquisition of 1,940,000 shares on November 07, 2007. Consequently, the total number of shares held in Treasury increased to 480,129,158. The filing does not provide comparative data against prior periods for financial performance.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities and is made in conformity with the Financial Services Authority's Disclosure and Transparency Rules.
Key Facts for Investor Verification
- Verify the total cost of the repurchase by multiplying 1,940,000 shares by 1,208.54 pence.
- Confirm the updated share count of 5,545,093,309 for calculating ownership percentages under Disclosure and Transparency Rules.
- Note that 8.66% of voting rights are now held in Treasury, which may impact earnings per share calculations and voting dynamics.
- Recognize that this filing is a transactional report and does not contain quarterly or annual financial performance data.